A Brief Introduction for the Dermatologist to a Novel Non-Dopaminergic Antipsychotic: Xanomeline-Trospium Chloride
SKIN The Journal of Cutaneous Medicine · 10.11.2026 · 10 (6) · 3548-3550
DOI: 10.25251/s9beg853 ↗Kurz gefasst
Fachartikel in der Zeitschrift SKIN The Journal of Cutaneous Medicine, online erschienen am 10.11.2026. Verfasst von Amelie Spangenberg und 3 weiteren Autor:innen. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Spangenberg, A., Bean, E. L., Brownstone, N. D., & Koo, J. Y. M. (2026). A Brief Introduction for the Dermatologist to a Novel Non-Dopaminergic Antipsychotic: Xanomeline-Trospium Chloride. SKIN The Journal of Cutaneous Medicine, 10(6), 3548-3550. https://doi.org/10.25251/s9beg853
Vancouver
Spangenberg A, Bean EL, Brownstone ND, Koo JYM. A Brief Introduction for the Dermatologist to a Novel Non-Dopaminergic Antipsychotic: Xanomeline-Trospium Chloride. SKIN The Journal of Cutaneous Medicine. 2026;10(6):3548-3550. doi:10.25251/s9beg853
BibTeX
@article{Spangenberg2026,
author = {Spangenberg, Amelie and Bean, Eric L. and Brownstone, Nicholas D. and Koo, John Y. M.},
title = {A Brief Introduction for the Dermatologist to a Novel Non-Dopaminergic Antipsychotic: Xanomeline-Trospium Chloride},
journal = {SKIN The Journal of Cutaneous Medicine},
year = {2026},
volume = {10},
number = {6},
pages = {3548--3550},
doi = {10.25251/s9beg853}
}
EUVIMED